Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA ...
Cannabix Technologies Inc. (the "Company or Cannabix") a developer of marijuana and alcohol breath testing devices, is pleased to announce that it has received its first product orders for BreathLogix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback